Amicus Therapeutics Inc (FOLD)

NASDAQ
Currency in USD
9.765
-0.005(-0.05%)
Real-time Data
FOLD Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected tomorrow
Fair Value
Day's Range
9.6809.940
52 wk Range
8.78514.020
Key Statistics
Edit
Prev. Close
9.77
Open
9.73
Day's Range
9.68-9.94
52 wk Range
8.785-14.02
Volume
607.92K
Average Vol. (3m)
2.29M
1-Year Change
-29%
Book Value / Share
0.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FOLD Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
17.091
Upside
+75.02%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

Amicus Therapeutics Inc Company Profile

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Compare FOLD to Peers and Sector

Metrics to compare
FOLD
Peers
Sector
Relationship
P/E Ratio
−27.9x−3.3x−0.7x
PEG Ratio
−0.66−0.070.00
Price / Book
16.4x2.4x2.6x
Price / LTM Sales
5.9x9.9x3.1x
Upside (Analyst Target)
74.0%136.1%47.6%
Fair Value Upside
Unlock14.7%7.7%Unlock

Analyst Ratings

9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.091
(+75.02% Upside)

Earnings

Latest Release
Nov 06, 2024
EPS / Forecast
0.10 / 0.0012
Revenue / Forecast
141.52M / 134.93M
EPS Revisions
Last 90 days

People Also Watch

2.670
RR
-2.91%
1.040
SES
+1.92%
38.53
LEGN
+5.81%
81.64
TEM
-8.72%
9.725
APLD
+6.75%

FAQ

What Is the Amicus (FOLD) Stock Price Today?

The Amicus stock price today is 9.765

What Stock Exchange Does Amicus Trade On?

Amicus is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Amicus?

The stock symbol for Amicus is "FOLD."

What Is the Amicus Market Cap?

As of today, Amicus market cap is 2.92B.

What is Amicus Earnings Per Share?

The Amicus EPS is -0.345.

What Is the Next Amicus Earnings Date?

Amicus will release its next earnings report on Feb 19, 2025.

From a Technical Analysis Perspective, Is FOLD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.